Figure 8

100Â ns MD simulation trajectory representing the RMSD assessment, ligand-receptor interaction profile and ligand-receptor interaction timeline for PhzR-HHL, PhzR-6-Gingerol, and PhzR-Curcumin complexes.
100Â ns MD simulation trajectory representing the RMSD assessment, ligand-receptor interaction profile and ligand-receptor interaction timeline for PhzR-HHL, PhzR-6-Gingerol, and PhzR-Curcumin complexes.